ArticleClinical cardiology2023

Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.

Xiaoxuan Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.